- SG$59.53m
- SG$54.96m
- $4.50m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.5 | 3.84 | 2.3 | 3.58 | 4.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8.13 | 8.87 | 12.6 | 13.1 | 11.4 |
Operating Profit | -2.63 | -5.02 | -10.3 | -9.52 | -6.89 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.137 | -12.9 | 2.65 | -17.3 | -34.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.695 | -3.95 | 6 | -15.2 | -34.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.474 | -3.73 | 6.56 | -14.5 | -34 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.474 | -3.73 | 6.56 | -14.5 | -34 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.001 | -0.005 | 0.008 | -0.017 | -0.037 |